Caption Management, LLC 89bio, Inc. Call Options Transaction History

Caption Management, LLC

  • $5.74 Billion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024
BUY
$8.13 - $13.77 $699,180 - $1.18 Million
86,000 New
86,000 $1 Million
Q3 2023

Nov 14, 2023
BUY
$15.06 - $19.41 $1.81 Million - $2.33 Million
120,000 New
120,000 $1.85 Million
Q1 2023

May 15, 2023
BUY
$10.48 - $16.94 $17.8 Million - $28.8 Million
1,699,100 New
1,699,100 $25.9 Million

Others Institutions Holding ETNB

# of Institutions
158
Shares Held
108M
Call Options Held
73.6K
Put Options Held
1.19M
View Full List

About 89bio, Inc.

ETNB Quotes by TradingView
  • Ticker ETNB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,484,500
  • Market Cap $371M
  • Description
  • 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...
More about ETNB
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email